GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Central Pharmaceuticals Ltd (DHA:CENTRALPHL) » Definitions » Pre-Tax Income

Central Pharmaceuticals (DHA:CENTRALPHL) Pre-Tax Income : BDT-71.36 Mil (TTM As of Sep. 2022)


View and export this data going back to 2013. Start your Free Trial

What is Central Pharmaceuticals Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Central Pharmaceuticals's pretax income for the three months ended in Sep. 2022 was BDT-9.74 Mil. Its pretax income for the trailing twelve months (TTM) ended in Sep. 2022 was BDT-71.36 Mil. Central Pharmaceuticals's pretax margin was -155.91%.

During the past 11 years, Central Pharmaceuticals's highest Pretax Margin was 33.80%. The lowest was -792.23%. And the median was 22.88%.


Central Pharmaceuticals Pre-Tax Income Historical Data

The historical data trend for Central Pharmaceuticals's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Central Pharmaceuticals Pre-Tax Income Chart

Central Pharmaceuticals Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 63.05 -1,109.85 -14.63 -70.82 -47.87

Central Pharmaceuticals Quarterly Data
Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Jun19 Sep19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Jun23
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -13.97 -9.92 -37.73 -9.74 -

Competitive Comparison of Central Pharmaceuticals's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, Central Pharmaceuticals's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Central Pharmaceuticals's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Central Pharmaceuticals's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Central Pharmaceuticals's Pre-Tax Income falls into.



Central Pharmaceuticals Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Central Pharmaceuticals's Pretax Income for the fiscal year that ended in Jun. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-39.443+0+-0.01+0.004+-8.417
=-47.87

Central Pharmaceuticals's Pretax Income for the quarter that ended in Sep. 2022 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-9.73+0+-0.01+0+0
=-9.74

Pre-Tax Income for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT-71.36 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Central Pharmaceuticals  (DHA:CENTRALPHL) Pre-Tax Income Explanation

Central Pharmaceuticals's Pretax Margin for the quarter that ended in Sep. 2022 is calculated as

Pretax Margin=Pretax Income/Revenue
=-9.74/6.247
=-155.91%

During the past 11 years, Central Pharmaceuticals's highest Pretax Margin was 33.80%. The lowest was -792.23%. And the median was 22.88%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Central Pharmaceuticals Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Central Pharmaceuticals's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Central Pharmaceuticals (DHA:CENTRALPHL) Business Description

Traded in Other Exchanges
N/A
Address
South West Darus Salam Road, 2-A/1, 2nd Floor, Mirpur - 1, Dhaka, BGD, 1216
Central Pharmaceuticals Ltd is engaged in the manufacturing and marketing of medicines in Bangladesh. The company manufactures finished formulation products for general people, hospitals, clinics, government organizations, corporations, and other non-government organizations. Its product portfolio encompasses therapeutic categories including gastrointestinal, anti-infective, vitamins and minerals, allergy cough and cold, analgesic and musculoskeletal, dermatological, oral rehydration salt, and others. The products are in the dosage forms of tablets, capsules, liquid, and ointments.

Central Pharmaceuticals (DHA:CENTRALPHL) Headlines

No Headlines